Research

Scientific work:

1. Grant RFBR  No.18-315-20019 (2018-2019) "New approaches to the genetics of clinical polymorphism and neurocognitive deficits in schizophrenia". Coinvestigator.

2. Grant RFBR  No. 17-29-06035 New approaches to the pharmacogenetics of antipsychotic-induced hyperprolactinaemia in patients with schizophrenia. 2.1 million rubles. (2017-2019) Coinvestigator.

3. Grant RSF № 14-35-00023 "Laboratory of pharmacogenetic research on personalized therapy of mental and neurodegenerative disorders." (2014-2016) Principal Investigator.

4. Grant RSF № 14-15-00480 "Search for the key biomarkers of the pathogenesis of socially significant endogenous mental disorders (2014-2016). Coinvestigator.

5. Grant RHSF № 14-06-00531a "Psychosocial, Ethnocultural and genetic determinants of alcohol dependence among the indigenous population of Siberia". (2014-2016) Coinvestigator.

Research outcomes:

Molecular genetic panels have been developed for predicting the development of hyperprolactinemia in schizophrenic patients, levodopa-induced dyskinesias in patients with Parkinson's disease, as well as predicting the response to antidepressant therapy (determination of responders and non-responders) in patients with depressive disorders.

Research interests:

Genetic, epigenetic studies of the pathogenesis of mental and neurodegenerative disorders. Pharmacogenetic studies of the side effects of pharmacotherapy in mental and neurodegenerative disorders.